The 41st Annual New Treatments in Chronic Liver Disease 2027 presents the latest advances in diagnosing, managing, and treating chronic liver diseases through updated clinical evidence and expert insights.
Key Topics
Hepatocellular carcinoma and liver mass evaluation
Metabolic liver disease and non-alcoholic fatty liver disease
Primary biliary cholangitis and primary sclerosing cholangitis
Chronic hepatitis B, C, and Delta hepatitis
Alcohol-related liver disease
End-stage liver disease complications, including ascites, thrombocytopenia, and hepatorenal syndrome
New therapeutic strategies and clinical trial data
Who should Attend
Physicians and hepatologists
Nurses, nurse practitioners, and physician assistants
Gastroenterologists and transplant specialists
Residents, fellows, and medical students
Healthcare professionals involved in liver disease management
41st Annual New Treatments in Chronic Liver Disease 2027 - Mar 2027, California, United States (12487)
Past Events
40th Annual New Treatments in Chronic Liver Disease 2026 - 14-16 Mar 2026, The Seabird Ocean Resort & Spa - Destination by Hyatt, Oceanside, California, United States (3031)
39th Annual New Treatments in Chronic Liver Disease 2025 - 15-16 Mar 2025, Coronado Island Marriott Resort & Spa, California, United States (34855)
38th Annual New Treatments in Chronic Liver Disease CME Conference - 16-17 Mar 2024, Coronado Island Marriott Resort & Spa, California, United States (23079)
37th Annual New Treatments in Chronic Liver Disease - 18-19 Mar 2023, San Diego Mission Bay Resort, California, United States (23078)
Important
Please, check "New Treatments in Chronic Liver Disease" official website for possible changes, before making any traveling arrangements
